Exact Mass: 280.143953
Exact Mass Matches: 280.143953
Found 164 metabolites which its exact mass value is equals to given mass value 280.143953
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Tyrosyl-Valine
C14H20N2O4 (280.14230000000003)
Tyrosyl-Valine is a dipeptide composed of tyrosine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Feruloyl-2-hydroxyputrescine
C14H20N2O4 (280.14230000000003)
Feruloyl-2-hydroxyputrescine is found in cereals and cereal products. Feruloyl-2-hydroxyputrescine is an alkaloid from Triticum aestivum (wheat). Alkaloid from Triticum aestivum (wheat). Feruloyl-2-hydroxyputrescine is found in wheat and cereals and cereal products.
7-(4-Hydroxyphenyl)-1-phenyl-4-hepten-3-one
7-(4-Hydroxyphenyl)-1-phenyl-4-hepten-3-one is found in herbs and spices. 7-(4-Hydroxyphenyl)-1-phenyl-4-hepten-3-one is a constituent of rhizomes of Alpinia officinarum (lesser galangal). Constituent of rhizomes of Alpinia officinarum (lesser galangal). 7-(4-Hydroxyphenyl)-1-phenyl-4-hepten-3-one is found in herbs and spices.
Valyltyrosine
C14H20N2O4 (280.14230000000003)
Valyltyrosine is a dipeptide composed of valine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. H-Val-Tyr-OH is an endogenous metabolite.
Lisofylline
C13H20N4O3 (280.15353300000004)
4-(1,3-Dihydroxy-4,4,5,5-tetramethyl-imidazolidin-2-yl)benzoic acid
C14H20N2O4 (280.14230000000003)
4-O-Methylhonokiol
4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research. 4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research. 4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research.
Albifylline
C13H20N4O3 (280.15353300000004)
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents
1,7-diphenyl-5-hydroxy-6-hepten-3-one
(5R,6E)-5-Hydroxy-1,7-diphenyl-6-hepten-3-one is the methylene chloride extract of Alpinia nutans, has antioxidant activity[1]. (5R,6E)-5-Hydroxy-1,7-diphenyl-6-hepten-3-one is the methylene chloride extract of Alpinia nutans, has antioxidant activity[1].
4-methoxyhonokiol
4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research. 4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research. 4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research.
2-(3-Methyl-1-butenyl)-5-(2-phenylethenyl)-1,3-benzenediol
9,10-Dihydro-4-ethenyl-1,8-dimethyl-2-methoxyphenanthrene-7-ol
3,8-Dimethyl-4-vinyl-7-methoxy-9,10-dihydrophenanthrene-1-ol
5-Hydroxy-7-(2-phenylethyl)-2,2-dimethyl-2H-1-benzopyran
2-(1-Methylethenyl)-4-phenethyl-2,3-dihydrobenzofuran-6-ol
2,2-Dimethyl-7-hydroxy-5-(2-phenylethyl)-2H-1-benzopyran
4-(2-hydroxy-3-isopropylaminopropoxy)phenylglyoxylic acid amide
C14H20N2O4 (280.14230000000003)
4-O-Methylhonokiol
4-O-Methylhonokiol is a natural product found in Magnolia virginiana, Magnolia obovata, and Magnolia officinalis with data available. 4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research. 4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research. 4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research.
3,8,8-Trimethyl-4,5,10,11-tetrahydrophenanthro[10,1-bc]pyran-9(8H)-one
3,5-Dihydroxy-2-(gamma,gamma-dimethylallyl)-stilben|trans-3,5-dimethoxy-2-prenylstilbene
1,1?-(E)-propenyl-4-methoxy-3,4?-oxyneolignan|ottomentosa
(2S,3S)-5-allyl-2,3-dihydro-2-(4-methoxyphenyl)-3-methylbenzofuran|4?-O-methylmiliumollin
(+)-conocarpan methyl ether|(2S,3S)-2,3-dihydro-2-(4-methoxyphenyl)-3-methyl-5-[1(E)-propenyl]benzofuran
Ac-(all-E)-1,7,9-Heptadecatriene-11,13,15-triyn-6-ol
4-[2-[2-Methoxy-5-(2-propenyl)phenyl]-2-propenyl]phenol
Lisofylline
C13H20N4O3 (280.15353300000004)
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D011838 - Radiation-Sensitizing Agents D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Dehydromiltirone
Dehydromiltirone is a natural product found in Salvia miltiorrhiza, Salvia miltiorrhiza var. miltiorrhiza, and Salvia prionitis with data available.
(E)-5-hydroxy-1,7-diphenylhept-1-en-3-one [IIN-based on: CCMSLIB00000845889]
(E)-5-hydroxy-1,7-diphenylhept-1-en-3-one [IIN-based: Match]
(R)-Lisofylline
C13H20N4O3 (280.15353300000004)
A 1-(5-hydroxyhexyl)-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione that has (R)-configuration. A synthetic small molecule which was under development for the treatment of type 1 diabetes mellitus.
(S)-Lisofylline
C13H20N4O3 (280.15353300000004)
A 1-(5-hydroxyhexyl)-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione that has (S)-configuration. It is the inactive optical enantiomer of (R)-lisofylline, an anti-inflammatory agent.
Tyr-val
C14H20N2O4 (280.14230000000003)
A dipeptide formed from L-tyrosine and L-valine residues.
Val-Tyr
C14H20N2O4 (280.14230000000003)
A dipeptide formed from L-valine and L-tyrosine residues. H-Val-Tyr-OH is an endogenous metabolite.
Feruloyl-2-hydroxyputrescine
C14H20N2O4 (280.14230000000003)
2-[4-[[tert-butyl(dimethyl)silyl]oxymethyl]phenyl]acetic acid
Tyrosyl-Valine
C14H20N2O4 (280.14230000000003)
2-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ACETIC ACID
(2-ACETYL-1,2,3,4-TETRAHYDROISOQUINOLIN-1-YL)ACETICACID
C14H20N2O4 (280.14230000000003)
[2-hydroxyimino-2-(3-methoxy-phenyl)-ethyl]-carbamic acid tert-butyl ester
C14H20N2O4 (280.14230000000003)
BIS-N,N-(TRIMETHYLSILYL)-N-PHENYLUREA
C13H24N2OSi2 (280.14270939999994)
Boc-(R)-3-Amino-4-(3-pyridyl)-butyric acid
C14H20N2O4 (280.14230000000003)
[4-(2-phenylpropan-2-yl)phenyl] 2-methylprop-2-enoate
[2-hydroxyimino-2-(4-methoxy-phenyl)-ethyl]-carbamic acid tert-butyl ester
C14H20N2O4 (280.14230000000003)
METHYL 3-(6-AMINOPYRIDIN-2-YL)-2-(TERT-BUTOXYCARBONYL)PROPANOATE
C14H20N2O4 (280.14230000000003)
Boc-(S)-3-Amino-4-(3-pyridyl)-butyric acid
C14H20N2O4 (280.14230000000003)
Boc-(S)-3-Amino-4-(4-pyridyl)-butyric acid
C14H20N2O4 (280.14230000000003)
(R)-TERT-BUTYL (1-OXO-1-(2-(PYRIDIN-2-YL)HYDRAZINYL)PROPAN-2-YL)CARBAMATE
C13H20N4O3 (280.15353300000004)
TERT-BUTYL 4-HYDROXY-2-OXO-5,6,8,9-TETRAHYDRO-1H-PYRIDO[2,3-D]AZEPINE-7(2H)-CARBOXYLATE
C14H20N2O4 (280.14230000000003)
(S)-TERT-BUTYL (1-OXO-1-(2-(PYRIDIN-2-YL)HYDRAZINYL)PROPAN-2-YL)CARBAMATE
C13H20N4O3 (280.15353300000004)
2-[(TERT-BUTOXY)CARBONYLAMINO]-N-(PHENYLMETHOXY)ACETAMIDE
C14H20N2O4 (280.14230000000003)
2,8-Diazaspiro[4.5]decan-1-one, 2-(phenylmethyl)-, hydrochloride (1:1)
2-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]-3-pyridin-3-ylpropanoic acid
C14H20N2O4 (280.14230000000003)
Ciclosidomine
C13H20N4O3 (280.15353300000004)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
ethyl 2-(5-{[(tert-butoxy)carbonyl]amino}pyridin-2-yl)acetate
C14H20N2O4 (280.14230000000003)
Boc-(R)-3-Amino-4-(4-pyridyl)-butyric acid
C14H20N2O4 (280.14230000000003)
1-BENZYL 2-TERT-BUTYL 1-METHYLHYDRAZINE-1,2-DICARBOXYLATE
C14H20N2O4 (280.14230000000003)
tert-butyl 4-(5-hydroxypyrimidin-2-yl)piperazine-1-carboxylate
C13H20N4O3 (280.15353300000004)
octahydro-2,6-dimethyl-3,8:4,7-dimethano-2,6-naphthyridine-4,8-dicarboxylic acid
C14H20N2O4 (280.14230000000003)
TERT-BUTYL 2-AMINO-4-HYDROXY-8,9-DIHYDRO-5H-PYRIMIDO[4,5-D]AZEPINE-7(6H)-CARBOXYLATE
C13H20N4O3 (280.15353300000004)
2-Methyl-2-propanyl 4-(4-formyl-1H-1,2,3-triazol-1-yl)-1-piperidi necarboxylate
C13H20N4O3 (280.15353300000004)
1,4-Phenanthrenedione, 7,8-dihydro-8,8-dimethyl-2-(1-methylethyl)-
2-[(2-Amino-3-methylbutanoyl)amino]-3-(4-hydroxyphenyl)propanoic acid
C14H20N2O4 (280.14230000000003)
1-(4-hydroxyphenyl)-7-phenyl-(6E)-hept-6-en-3-one
A diarylheptanoid that is hept-6-en-3-one substituted by a 4-hydroxyphenyl group at position 1 and a phenyl group at position 7 respectively. It has been isolated from the rhizomes of Curcuma kwangsiensis.
N-(2-pyridinylmethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[5,1-b]quinazolin-9-amine
(E)-N-(4-amino-3-hydroxybutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide
C14H20N2O4 (280.14230000000003)
N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)oxirane-2-carboxamide
C14H20N2O4 (280.14230000000003)
1-(5-hydroxyhexyl)-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione
C13H20N4O3 (280.15353300000004)
A dimethylxanthine that is 3,7-dihydro-1H-purine-2,6-dione which is substituted at positions 1,3 and 7 by a 5-hydroxyhexyl group, methyl group and methyl group, respectively.
3-methyl-8-(2-phenylethyl)-2,5-dihydro-1-benzoxepin-6-ol
4'-methoxy-3',5-bis[(1e)-prop-1-en-1-yl]-[1,1'-biphenyl]-2-ol
4-ethenyl-9,10-dihydro-7-methoxy-1,8-dimethyl-2-phenanthrenol
{"Ingredient_id": "HBIN010372","Ingredient_name": "4-ethenyl-9,10-dihydro-7-methoxy-1,8-dimethyl-2-phenanthrenol","Alias": "NA","Ingredient_formula": "C19H20O2","Ingredient_Smile": "NA","Ingredient_weight": "280.366","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7844","PubChem_id": "NA","DrugBank_id": "NA"}
6'-O- methylhonokiol
{"Ingredient_id": "HBIN012696","Ingredient_name": "6'-O- methylhonokiol","Alias": "6'-o-methylhonokiol","Ingredient_formula": "C19H20O2","Ingredient_Smile": "COC1=C(C=C(C=C1)C2=C(C=CC(=C2)CC=C)O)CC=C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "36325;14483","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-methoxy-1-[(4-methoxyphenyl)methyl]-1,2-dihydronaphthalene
2-(3-methylbut-2-en-1-yl)-5-(2-phenylethenyl)benzene-1,3-diol
6,6,14-trimethyl-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1,7,9(17),13,15-pentaen-5-one
4-{2-[2-methoxy-5-(prop-2-en-1-yl)phenyl]prop-2-en-1-yl}phenol
(2s)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-(4-hydroxyphenyl)propanoic acid
C14H20N2O4 (280.14230000000003)
4-(2-{2-methoxy-5-[(1e)-prop-1-en-1-yl]phenyl}prop-2-en-1-yl)phenol
3-methyl-n-{4-methyl-1,5-dioxo-5ah,6h,7h,8h-pyrrolo[1,2-c][1,3]oxazepin-3-yl}butanimidic acid
C14H20N2O4 (280.14230000000003)
(1r)-6-methoxy-1-[(4-methoxyphenyl)methyl]-1,2-dihydronaphthalene
3'-methoxy-4',5-bis(prop-2-en-1-yl)-[1,1'-biphenyl]-2-ol
2'-methoxy-3,5'-bis(prop-2-en-1-yl)-[1,1'-biphenyl]-4-ol
4-ethenyl-7-methoxy-3,8-dimethyl-9,10-dihydrophenanthren-1-ol
2'-methoxy-5,5'-bis(prop-1-en-1-yl)-[1,1'-biphenyl]-2-ol
4-{2-[2-methoxy-5-(prop-1-en-1-yl)phenyl]prop-2-en-1-yl}phenol
(1s,3r,5r,6s,7r)-3,7-dihydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl 1-methylpyrrole-2-carboxylate
C14H20N2O4 (280.14230000000003)
2'-methoxy-5,5'-bis[(1e)-prop-1-en-1-yl]-[1,1'-biphenyl]-2-ol
(2s,4r)-4-methyl-9-(2-phenylethyl)-6-oxatricyclo[5.4.0.0²,⁴]undeca-1(11),7,9-trien-11-ol
5-ethenyl-7-methoxy-1,8-dimethyl-9,10-dihydrophenanthren-2-ol
n-[(5s,6s,7s,7as)-6,7-dihydroxy-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-3-yl]-3-methylbut-2-enamide
C14H20N2O4 (280.14230000000003)
(1r,3r,5s,6s,7s)-6,7-dihydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 1-methylpyrrole-2-carboxylate
C14H20N2O4 (280.14230000000003)
4-methyl-9-(2-phenylethyl)-6-oxatricyclo[5.4.0.0²,⁴]undeca-1(11),7,9-trien-11-ol
n-(6,7-dihydroxy-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-3-yl)-3-methylbut-2-enamide
C14H20N2O4 (280.14230000000003)